Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Affini-T Therapeutics

Main (gene editing) focus: Next-generation cell therapies

Company stage: Pre-clinical

Diseases: Solid tumours

Genome editing tool: CRISPR

Funding stage: Private

Location: Boston, MA, USA

Website: https://affinittx.com/

Pipeline: https://affinittx.com/pipeline/

Partners: Metagenomi

Affini-T Therapeutics is focused on developing pioneering engineered T cell receptor (TCR) T cell therapies. The company's involvement in the gene-editing space comes through its partnership with Metagenomi, although lead programmes have yet to be announced as well as the specifics regarding the gene-editing system in use.

Tags

HashtagCompanyHashtagAffini-T Therapeutics

Company: Affini-T Therapeutics
close
Search CRISPR Medicine